AbbVie Inc.
History
| Year | Detail |
|---|---|
| 2013 | AbbVie celebrated launch as new biopharmaceutical company.. |
| 2014 | AbbVie announced novel collaboration on aging with Calico. |
| 2014 | The first medicine developed independently by AbbVie for chronic HCV was approved in the U.S. |
| 2015 | U.S. FDA approval for the treatment of moderate to severe hidradenitis suppurativa. |
| 2016 | AbbVie opened the Cambridge Research Center. |
| 2017 | MAVIRET and MAVYRET (glecaprevir/pibrentasvir) was approved in U.S., European Union and Japan. |
| 2020 | AbbVie acquired Allergan. |
| 2021 | AbbVie opens new facility in the Bay Area. |
| 2022 | AbbVie and the North Chicago Community Unit School District 187 opened the new Neal Math and Science Academy. |
| 2024 | AbbVie and OSE Immunotherapeutics announce partnership to develop a novel Monoclonal Antibody for the treatment of Chronic Inflammation. |
BCC Research Beacon 